Items Tagged ‘Management and Prevention of Neutropenia Supportive Care’

February 25th, 2013

Neulasta Significantly Reduces Febrile Neutropenia Among Colorectal Cancer Patients Receiving Chemotherapy Plus Avasatin

By

Neulasta® (pegfilgrastim) significantly reduced the incidence of grade 3/4 febrile neutropenia among patients with locally advanced or metastatic colorectal cancer who received chemotherapy with FOLFOX or FOLFIRI followed by Avastin® (bevacizumab), according to the results of a study presented at the 2013 Gastrointestinal Cancers Symposium in San Francisco. Although chemotherapy improves outcomes for many cancer […]

View full entry

Tags: Colon Cancer, Management and Prevention of Neutropenia Supportive Care, News, Stage IV (D)/Relapsed Colon Cancer, Supportive Care


August 2nd, 2012

Naproxen May Relieve Bone Pain Associated with Neulasta

By

Twice-daily naproxen is effective in reducing the incidence and severity of bone pain associated with the use of Neulasta® (pegfilgrastim), according to the results of a study published in the Journal of Clinical Oncology. Neulasta is a blood cell growth factor that can be an important addition to the chemotherapy regimen for many patients. Although […]

View full entry

Tags: General, Management and Prevention of Neutropenia Supportive Care, News, Supportive Care